Drugs Information:
Pomalidomide
Basic Information
|
||
ID | DDInter1491 | |
Drug Type | small molecule | |
Molecular Formula | C13H11N3O4 | |
Molecular Weight | 273.244 | |
CAS Number | 19171-19-8 | |
Description | Pomalidomide, an analogue of thalidomide, is an immunomodulatory antineoplastic agent. FDA approved on February 8, 2013. | |
ATC Classification | L04AX06 | |
IUPAC Name | 4-amino-2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione | |
InChI | UVSMNLNDYGZFPF-UHFFFAOYSA-N | |
Canonical SMILES | NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O | |
Useful Links | DrugBank ChEBI PubChem Substance KEGG Drug ChemSpider BindingDB Wikipedia ChEMBL |
Interactions with
Pomalidomide
Filter:
Severity level | ID | Name | Mechanism | Detail |
---|
Interactions with diseases
Filter:
Severity level | Disease name | Text | References |
---|
Interactions with foods
Filter:
Severity level | Food name | Description | Management | Mechanism | References |
---|
Interactions with compound preparation
Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
---|